How to win: Transitional Drugs 7

About this contract

The provision of Drugs which have lost or are shortly to lose exclusivity, namely Eculizumab; Icatibant; Nintedanib; Omalizumab; Tocilizumab

How to win contracts like this

• ✓Answer against the marking scheme, not the question text — NHS Wales Shared Services Partnership - Procurement Services (hosted by Velindre NHS Trust) scores each response, so map your evidence to the published criteria and weightings.
• ✓At £53,566,932, expect quality and social value to carry a large share of the score — price alone rarely wins goods work.
• ✓Show recent, comparable delivery: name similar goods contracts you've delivered for public bodies, with measurable outcomes.
• ✓Start early: it closes 29 May 2026 and a strong bid takes iteration.

BidWriter drafts your responses from your company profile, scores them against the marking scheme, and tracks your whole pipeline. Free to start — no card needed.

Related resources

Similar contracts